OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
April 05, 2023
Sartorius’ acquisition of Polyplus is designed to strengthen its cell and gene therapy capabilities.
Interviews hosted on-site at the Emerson Automation Exchange in Grapevine, Texas, from October 24th to October 28th, 2022.
Mass spectrometric techniques are providing insights in critical RNA-based therapeutic areas.
April 04, 2023
A CPHI North America panel discussion forewarns that CDMO supply chains are potentially the biggest single risk to product resilience.
April 03, 2023
Webinar Date/Time: Tue, May 23, 2023 11:00 AM EDT
As new manufacturing processes and technologies are introduced to meet demand and overcome challenges, understanding also needs to improve to ensure the right balance is achieved.
Limitations in production platforms have impeded continuous manufacturing for advanced therapies.
Manufacturers and suppliers join forces to reduce the pharmaceutical industry’s carbon footprint.
April 02, 2023
Alternative approaches to freeze-drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.
Contract testing services demonstrate a major increase in the speed and efficiency of testing using new testing methods and technologies.